Rosenberg (pictured) was previously president and general manager at the life sciences, ecosystem and public sector business unit at Datavant.

Fitzgerald will remain with Apollo Intelligence as a board adviser, and said: “Over the last five years, Apollo’s talented team has doubled revenue by delivering highly differentiated product innovation and superior client satisfaction.

“Tal’s leadership and deep expertise in life sciences, technology, and building transformational industry partnerships, will help drive our next phase of growth. I am thrilled that Apollo’s more than 300 clients, employees, and our future vision and success will be in such capable hands.”

Rosenberg added: “Apollo delivers on a critical need to accelerate drug development and launch effectiveness through its real-time primary market insights, and we are well-positioned to broaden our insight offerings through new data ingestion and analytics.

“I am thrilled to join the team as we transform the market, bringing greater value to clients and partners.”